Health System

Existing surveillance networks can track influenza-like illness and lead to improved assessments on impact, prevalence, and severity of COVID-19.

In the newest episode of Over the Counter, 3 experts on professional burnout discuss the factors at play, and the impact the COVID-19 pandemic may be having on rates of pharmacist burnout.

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.

A new poll by Gallup and West Health found that a majority of Americans have expressed numerous health care system-related concerns, including rising costs of drugs, insurance premiums, and health care in response to COVID-19.

“Telehealth has kept the entire health care system afloat and has enabled patients to continue to receive care,” the American Telemedicine Association’s president said in a testimony.

On February 27, 2020, the FDA approved an intravenous solution of amisulpride (Barhemsys; Acacia Pharma) to treat and prevent postoperative nausea and vomiting.

Here's a roundup of this week's coronavirus-related news.

How can we care for our elderly during a pandemic? Pharmacists practicing in long term care settings discuss the changes and response from their facilities, plus insights on a potential treatment specific to older adults for COVID-19.

Via a new web platform, pharmacy technicians are sharing their personal challenges during the coronavirus disease 2019 (COVID-19) pandemic.

A poster presented at ADA’s 80th Scientific Sessions examines the effects of interactive pharmacist insulin teaching for patients with diabetes prior to hospital discharge.

Oncology pharmacy practitioners highlight challenges amid the pandemic, such as limited access to personal protective equipment and essential medications.

Though antibiotics are crucial, concern about overuse in hospitals and inappropriate prescribing practices fuels debate about the complex relationship between antibiotic use and antimicrobial resistance.

Officials with the FDA have approved imipenem, cilastatin, and relebactam (Recarbrio, Merck) for the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia. 

An analysis found that US patients with COVID-19 are experiencing longer hospital stays and higher rates of ICU admissions than patients in China.

The findings, which were presented virtually in the 2020 ASCO Virtual Scientific Program, included the association between treatment with hydroxychloroquine plus azithromycin and increased risk of death.

The US Department of Health & Human Services has left it up to state health departments to decide how to distribute remdesivir to hospitals.

Today, the American Society of Health-System Pharmacists (ASHP) sent a letter to Vice President Mike Pence to urge the transparent and orderly allocation of remdesivir among hospitals

A case report from NYU Langone Health assessed the use of both urgent and non-urgent telemedicine visits.

Here's the roundup of the latest coronavirus-related news.

The study examined the effects of unprotected, prolonged patient contact, along with certain exposures, on the risk of health care providers becoming infected with COVID-19.

Here's a roundup of the latest coronavirus-related news.

Merck has announced the US launch of trastuzumab-dttb (Ontruzant), a biosimilar to trastuzumab (Herceptin), in both 150-mg single-dose vials and 420-mg multiple-dose vials.

In part 2 of our video interview, Robert Brunault, PharmD, a clinical pharmacy specialist in hematology and oncology at Rhode Island Hospital and the Lifespan Cancer Institute, discussed drug shortages, FDA emergency use authorizations, and the biggest concerns for pharmacists.

Here's a roundup of the latest coronavirus-related news.

The letter asks the vice president to increase manufacturing of these medications based on current projections of critical care patient volume.

What does it mean for patients?

Pharmacists are positioned to play a key role in preventing or catching errors that can occur at the various stages of the drug-use process: prescribing, dispensing, and administration.

The FDA’s public- and private-sector partnership will expedite thousands of units of plasma to patients with severe COVID-19 symptoms, the news release said.

Facing disruptions in medical mask supplies, some hospital staff are re-using masks and using alternative types, according to a new survey.

Here's a roundup of the latest coronavirus-related news.